Bilibili Down Over 13%, on Pace for Largest Percent Decrease Since October 2022 — Data Talk
Bilibili, Inc. Sponsored ADR Class Z (BILI) is currently at $13.62, down $2.07 or 13.17%
--Would be lowest close since May 1, 2024, when it closed at $12.73
--On pace for largest percent decrease since Oct. 24, 2022, when it fell 16.83%
--Currently down three of the past four days
--Up 7.71% month-to-date
--Up 11.87% year-to-date
--Down 91.29% from its all-time closing high of $156.37 on Feb. 10, 2021
--Down 17.73% from 52 weeks ago (May 25, 2023), when it closed at $16.55
--Down 28.61% from its 52-week closing high of $19.07 on July 31, 2023
--Up 52.29% from its 52-week closing low of $8.94 on Feb. 2, 2024
--Traded as low as $13.51; lowest intraday level since May 8, 2024, when it hit $13.44
--Down 13.84% at today's intraday low; largest intraday percent decrease since Dec. 12, 2022, when it fell as much as 14.13%
All data as of 2:39:55 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 23, 2024 14:58 ET (18:58 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations